Assignment no.

Course Name: POM

Submitted To: Mr. Faisal Qadeer

Submitted By: Sikander Ahmad (BSAF-611)

Muhammad Karam BSAF-659)

Muhammad Tayyab (BSAF-602)

Submission Date: 24th Feb, 2023

 ScinoPharm

1. ORGANIZATION PROFILE:
1.1 Vision and Mission:
ScinoPharm Taiwan Ltd is a Taiwan-based company mainly engaged in the
research, development, manufacture and sale of active pharmaceutical
ingredients. The main products include active pharmaceutical ingredients,
protein drugs, oligonucleotides, peptides, injection preparations, new small
molecule drugs and other chemical raw materials. The Company is also
engaged in the provision of consulting and biotechnology services for related
products, the international trading of products, as well as the provision of
customized full-process services such as chemical molecular component
synthesis, process development and commercial mass production

1.2 Brief History:

Founded in 1997, with initial on-site operations beginning in November 1999,

ScinoPharm offers a wide array of process R&D services and API manufacturing
capabilities designed to satisfy customers' exact requirements and facilitate their
rapid market introductions. ScinoPharm specializes in process R&D and the
production of CGMP Active Pharmaceutical Ingredients (APIs).

1.2 Line of Business:

SinoPharm is a multinational medicine manufacturing organization with
main line of business in:
  Manufacturing
 Marketing
 R&D and Innovation
 Supply Chain
 Exports

2. ORGANIZATIONAL STRUCTURE:
2.1 Organizational Chart:

2.2 Specialization:
CCL has variety of domains but they are specialized in:

 R&D
 Modern Manufacturing Plant
 Vast Distribution Setup
 Covid-19 Vaccine

Span of Management:
Over more than 128000 people in span of management

2.3 Departmentalization:
  Manufacturing
 Quality control
 Research Institute
 R&D and Innovation
 Pharmacovigilance

Strengths:
Good and High-quality Manufacturing
Good quality Control

Good Customer Services

Weakness:
No weakness as such found.

2.4 Coordination Mechanism:

Standardization of business operations
The standardization of staff skills and outputs

3. DESIGN FITNESS:
3.1 Strategy and Structure:
 By reaching a wider patient population and accelerating the impact of clinical
trials, we can:
 Promote social change;
 Ensure that our medicines reach the diverse range of patients affected by
the diseases they treat;
 Deliver better consumer insight through an employee population that
mirrors our patient population.
 Fostering creativity by incorporating diversity of thought and experience;
 Recruiting, developing, and maintaining high-quality personnel from a large
and diverse talent pool
 3.2 Technology:
For a wide range of customers, it produces high-quality, reasonably
priced healthcare goods in accredited production facilities. Having been
in the manufacturing business for more than 20 years, we have a
national first mover advantage. From straightforward oral liquids,
tablets, or capsules to modified-release oral solids like hydrophilic-
matrix tablets, oral solutions, and emulsions, our pharmaceutical
manufacturing and packaging capabilities are extensive.

• Synthetic drug candidate research and process development;

• cGMP-compliant API production and supply;

• Commercial API production and delivery.

4. RECOMMENDATON ABOUT STRUCTURE:

ScinoPharm is a pharmaceutical industry that is developing quickly and has
excellent management. Its success, which is reflected in the variety and diversity
of its offerings in both goods and services, is attributable to the excellent
administration of numerous divisions that operate concurrently under various
leaderships as indicated by the hierarchical structure. It's distinct for the reasons
listed below:

• Synthetic drug candidate research and process development;

• cGMP-compliant API production and supply;

• Commercial API production and delivery.

The research and development section at ScinoPharm is quite active, and they
developed a COVID vaccine. Also, because they have few items, they need to
develop their production department in order to provide technical services. Also,
ScinoPharm should concentrate on expanding its exports since the largest chain
pharmacies do not carry their items.